Trinuclear μ-oxo-centered iron(III) isobutyrate clusters readily react with polyalcohol organic ligands under one-pot synthesis conditions. Depending on the ligand, solvent, and temperature, a range of hexa-, dodeca-, and doicosanuclear iron(III) oxo-hydroxo condensation products, isolated as (mdeaH)[FeO(thme)Cl]·0.5(MeCN)·0.5(HO) (1), [FeO(OH)(teda)(N)(MeO)]N(NO)(MeO)·2.5(HO) (2), [FeO(teda)Cl]·6(CHCl) (3), [FeO(OH)(OCCHMe)(bdea)(EtO)(HO)]·2(EtOH)·5(MeCN)·6(HO) (4), and [FeO(OH)(OCCHMe)(mdea)(EtO)(HO)](NO)·EtOH·HO (5), where tedaH = N, N, N', N'-tetrakis(2-hydroxyethyl)ethylenediamine; thmeH = 1,1,1-tris(hydroxymethyl)ethane; mdeaH = N-methyldiethanolamine; and bdeaH = N-butyldiethanolamine. Complete carboxylate metathesis in the {Fe} precursor complexes by thme or teda and the agglomeration of the formed species under solvothermal conditions afforded carboxylate-free {Fe} product (1) in MeCN/CHCl or {Fe} complexes (2 and 3) in MeOH/EtOH and CHCl/thf, respectively (thf = tetrahydrofuran). Single-crystal X-ray diffraction analyses revealed that 1 contains a [FeO(thme)Cl] cluster anion with a Lindqvist-type {Fe(μ-O)} core motif, charge-compensated by two protonated mdeaH cations. 2 comprises a [FeO(OH)(teda)(N)(MeO)] cation with a {FeO(OH)} core, whereas 3 contains a charge-neutral [FeO(teda)(Cl)] complex with an {FeO} core. Finally, employing flexible bdeaH or mdeaH ligands under soft reaction conditions afforded giant {Fe} oxo-hydroxo complexes (4 and 5) with a central {Fe} layer sandwiched between two outer {Fe} groups. Magnetic studies of 1-5 revealed strong antiferromagnetic coupling between the Fe spin centers in all clusters.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.inorgchem.8b00994DOI Listing

Publication Analysis

Top Keywords

conditions afforded
8
{fe}
7
tuning condensation
4
condensation degree
4
degree {fe}
4
{fe} oxo
4
oxo clusters
4
clusters ligand
4
ligand metathesis
4
metathesis temperature
4

Similar Publications

Background: Alcohol-associated hepatitis (AH) leads to high rates of mortality and health care costs. Understanding the immediate costs after an AH diagnosis and identifying key cost factors is crucial for health care policies and clinical decisions.

Objectives: This study quantifies medical costs within 30 days of an AH diagnosis across outpatient (OP), emergency department (ED), and inpatient (IP) settings.

View Article and Find Full Text PDF

Objectives: This longitudinal experimental study aimed to profile audiometric hearing loss, explore the feasibility and efficacy of low-cost hearing devices, and examine their social and emotional impact on participants in South Sudan, a low-resource humanitarian setting.

Design: We performed pure tone hearing screenings on adults with self-reported hearing disability, randomly providing eligible participants with one of two inexpensive devices-Asana Pro 800, a non-customizable hearing device fit unilaterally, or the Super Ear SE9000, a hand-held amplifier with headphones given one per individual.

Study Sample: Between October 2022 and January 2023, 142 adults underwent hearing screening at the Juba Teaching Hospital ENT clinic, of whom 19 eligible individuals were provided with hearing devices.

View Article and Find Full Text PDF

Background And Purpose: This study aims to assess the disease burden and care quality along with cross-country inequalities for stroke at global, regional, and national levels from 1990 to 2021.

Methods: Data on stroke were extracted from the Global Burden of Disease (GBD) study 2021 for the globe, five sociodemographic index (SDI) regions, 21 GBD regions, and 204 countries/territories. The disease burden was quantified using the age-standardized disability-adjusted life years rate (ASDR).

View Article and Find Full Text PDF

Background: Male breast cancer (MBC) is rare and often treated using evidence from female breast cancer (BC) trials due to limited male participation. Previous estimates lacked global coverage and completeness. We aimed to quantify the global MBC burden from 1990 to 2021 and evaluate its current status and trends.

View Article and Find Full Text PDF

As the main inhibitory neurotransmission system, the GABAergic system poses an interesting yet underutilized target for molecular brain imaging. While PET imaging of postsynaptic GABAergic neurons has been accomplished using radiolabeled benzodiazepines targeting the GABA receptor, the development of presynaptic radioligands targeting GABA transporter 1 (GAT1) has been unsuccessful thus far. Therefore, we developed a novel GAT1-addressing radioligand and investigated its applicability as a PET tracer in rodents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!